U.S. Glucose Testing Markets 2016 - Non-Invasive and Minimally-Invasive Testing Now Represent Major New Areas for the Application of IVD Testing

Wednesday, January 13, 2016 11:56 AM UTC

Dublin, Jan. 13, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/9tnsnk/u_s_glucose) has announced the addition of the "U.S. Glucose Testing Markets" report to their offering.

U.S. glucose testing is undergoing a significant transition, driven by new analytical technologies and developments in diabetes treatment. Although the blood glucose testing segment of the in vitro diagnostics (IVD) industry is mature, several segments of the market, such as home testing devices for diabetes management and point of care (POC) instruments for use in professional settings, will exhibit strong growth. Direct access testing has emerged as a strong force in the blood glucose testing segment, and non-invasive and minimally-invasive testing now represent major new areas for the application of IVD testing.

This report describes the specific market segments for blood glucose testing and diabetes management in the U.S. market. It reviews all of the generally-accepted clinical analytical methods that are currently in use today for measuring serum, plasma or whole-blood glucose concentrations. Additionally, this study examines clinical measurement devices, reagents and supplies as utilized in hospitals, clinics, doctor's offices and at-home care locations.

Moreover, it analyzes almost all of the companies known to be marketing, manufacturing or developing glucose testing products for the U.S. market. Each company is discussed in extensive depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company's market position.

Key Topics Covered:

1. Overview

2. Diabetes

3. Market Analysis: Size, Growth, Share and Competitors

4. Glucose Diagnostic and Monitoring Recommendations

5. Glucose Testing Technology Platforms and Consumable Products

6. Glucose Testing Devices on the Market

7. Business Trends in Glucose Testing

8. Technology Trends

9. Company Profiles

Companies Mentioned

Abaxis, Inc.
Abbott Laboratories
ACON Laboratories
AgaMatrix
Alere
Allmedicus
Amedica Biotech
A. Menarini Diagnostics
Apex Biotechnology Corporation
Arkray
Bayer
B. Braun Melsungen
Beckman Coulter
Bionime
Bio-Rad Laboratories, Inc.
BioTex
Calisto Medical
Cambridge Sensors
DexCom
Diagnostic Devices/Prodigy Diabetes Care
DiaSys
Echo Therapeutics
Entra Health Systems
Fora Care
Freedom Meditech
Genesis Health Technologies
GenExel-Sein
GlucoPlus
GluMetrics
GlySens
GlySure Limited
Grove Instruments

For more information visit http://www.researchandmarkets.com/research/9tnsnk/u_s_glucose



CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]

         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716

         Sector: Glucose Testing

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

U.S. Glucose Testing Markets 2016 - Non-Invasive and Minimally-Invasive Testing Now Represent Major New Areas for the Application of IVD Testing

Editor's Picks

Welcome to EconoTimes